Application of next generation sequencing

Next generation sequencing and WIN therapeutics

Identifying targets with systems medicine

Shortening the timeline for clinical drug developments

Building international collaborations and the WINTHER trial

GFI is crucial for AML1-ETO induced acute myeloid leukemia

Signaling and targeting cellular pathways in leukaemia metabolism

Whole genome sequence analysis for acute lymphoblastic leukaemia

Next generation sequencing and the monoclonal structure of multiple myeloma

Mouse models and proteomics tackling acute lymphoblastic leukaemia

New drugs for relapsed and refractory Hodgkin's lymphoma

Insight in to the EMILIA trial and systemic challenges with neoadjuvant therapy